Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Iveta Mareschová"'
Autor:
J. Vinklárková, Doubek M, Daniela Zackova, Martin Klabusay, Tomas Buchler, Alexandra Oltová, Jiri Adler, Jiri Mayer, E. Janovská, Jiri Vorlicek, Eva Krahulcová, Karel Indrak, Edgar Faber, Ladislav Dušek, Petr Kuglík, Korístek Z, Miroslav Penka, Roman Hájek, Iveta Mareschová, Ludmila Bourková
Publikováno v:
Medical Oncology. 20:69-76
Interleukin-2 (IL-2) is able to generate nonspecific cytotoxic effectors from hematopoietic precursors. We evaluated the feasibility and efficacy of chronic myeloid leukemia (CML) treatment with autologous hematopoietic stem cell transplantation (HSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44f3c2415d2475b31084855afe38d173
https://doi.org/10.1385/mo:20:1:69
https://doi.org/10.1385/mo:20:1:69
Autor:
Roman, Hájek, Daniela, Zácková, Tomás, Büchler, Miroslav, Penka, Eva, Krahulcová, Zdenĕk, Korístek, Jaroslava, Vinklárková, Jiri, Adler, Eva, Janovská, Karel, Indrák, Edgar, Faber, Michal, Doubek, Martin, Klabusay, Alexandra, Oltová, Petr, Kuglík, Ludmila, Bourková, Ladislav, Dusek, Iveta, Mareschová, Jiri, Mayer, Jiri, Vorlícek
Publikováno v:
Medical oncology (Northwood, London, England). 20(1)
Interleukin-2 (IL-2) is able to generate nonspecific cytotoxic effectors from hematopoietic precursors. We evaluated the feasibility and efficacy of chronic myeloid leukemia (CML) treatment with autologous hematopoietic stem cell transplantation (HSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3991b221133f69c127010a381f4b9d6e
https://pubmed.ncbi.nlm.nih.gov/12665687
https://pubmed.ncbi.nlm.nih.gov/12665687